VADUZ, Liechtenstein, May 15, 2024 /PRNewswire/ — RefluxStop™ on path to become standard of care for acid reflux treatment Significant events in the first quarter of 2024 Submitted Premarket Approval (PMA) application for RefluxStop™ to U.S. FDA First of three modules submitted Next two…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.